ADNEURIS THERAPEUTICS, INC.

Lobbying client · New Jersey · filed 2026 to 2026

biopharmaceutical company

$15,000 Reported spend

2 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page is grouped by the client's LDA id (73661), not by name.

Firms hired 1

MAD GLOBAL STRATEGY $15,000 2 filings

Reported by year 1 year

2026 $15,000 2 filings

Issues lobbied 2

Pharmacy 2
Health Issues 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 1

SENATE 1

Recent filings 2 total

Q2

MAD GLOBAL STRATEGY

2nd Quarter (Apr 1 - June 30) 2026 · Senate · $15,000 income · posted Jul 1, 2026

View → RR

MAD GLOBAL STRATEGY

2nd Quarter (Apr 1 - June 30) 2026 · posted Jun 24, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.